High induction dosing of risankizumab in patients with moderate-to-severe plaque psoriasis: Interim results from the phase 2 KNOCKOUT study

被引：0
|
作者：
Blauvelt, A. [1 ]
Gudjonsson, J. [2 ]
Matheson, R. [1 ]
Liu, R. [3 ]
Shi, L. [3 ]
Photowala, H. [3 ]
Ehst, B. [1 ]
机构：
[1] Oregon Med Res Ctr, Portland, OR USA
[2] Univ Michigan, Dept Dermatol, Sch Med, Ann Arbor, MI USA
[3] AbbVie Inc, N Chicago, IL USA
来源：
JOURNAL OF INVESTIGATIVE DERMATOLOGY | 2023年 / 143卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
LB1703
引用
收藏
页码：B16 / B16
页数：1
相关论文
共 50 条
  • [21] RNA-seq genomic analysis demonstrated the molecular efficacy of Risankizumab in a moderate-to-severe plaque psoriasis phase 2 clinical study
    Pakozdi, T.
    Georgantas, R.
    Grebe, K.
    Davis, W.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2018, 138 (05) : S59 - S59
  • [22] RNA-seq genomic analysis demonstrated the molecular efficacy of risankizumab in a moderate-to-severe plaque psoriasis phase 2 clinical study
    Pakozdi, T.
    Georgantas, R. W.
    Grebe, K. M.
    Visvanathan, S.
    Baum, P.
    Davis, W.
    EXPERIMENTAL DERMATOLOGY, 2018, 27 : 21 - 21
  • [23] Matching-Adjusted Indirect Comparison of Risankizumab Versus Deucravacitinib in Patients with Moderate-to-Severe Plaque Psoriasis
    April W. Armstrong
    Ahmed M. Soliman
    Paolo Gisondi
    Siran Fang
    Manish Patel
    Bruce Strober
    Dermatology and Therapy, 2024, 14 (11) : 3071 - 3081
  • [24] Disease severity in moderate-to-severe plaque psoriasis: Results from the Belgian REDISCOVER study
    Hillary, Tom
    Ghys, Liesbeth F. E.
    Willaert, Fabienne
    Swimberghe, Sandra
    Lecuyer, Myriam
    Ghislain, Pierre-Dominique
    Morrens, Joachim
    Lambert, Jo L. W.
    JEADV CLINICAL PRACTICE, 2024,
  • [25] Disease severity in moderate-to-severe plaque psoriasis: results from the Belgian REDISCOVER study
    Hillary, Tom
    Ghys, Liesbeth
    Willaert, Fabienne
    Swimberghe, Sandra
    Lecuyer, Myriam
    Ghislain, Pierre-Dominique
    Morrens, Joachim
    Lambert, Jo
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 89 (03) : AB37 - AB37
  • [26] Risankizumab Efficacy for Moderate-to-Severe Plaque Psoriasis over 256 Weeks in Patients with Prior Biologic Treatments
    Crowley, Jeffrey
    Hong, Chih-Ho
    Gooderham, Melinda
    Kokolakis, Georgios
    Photowala, Huzefa
    Rubant, Simone
    Zhan, Tianyu
    Blauvelt, Andrew
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 89 (03) : AB82 - AB82
  • [27] Real world experience of brodalumab treatment in patients with moderate-to-severe plaque psoriasis in the Greek population: Results from an interim analysis of the BrIDGE study
    Rigopoulos, Dimitrios
    Angelakopoulos, Charalampos
    Apalla, Zoi
    Georgiou, Sophia
    Delli, Florentina
    Drosos, Alexandros
    Zafiriou, Efterpi
    Katsantonis, John
    Lazaridou, Elisavet
    Panagakis, Pantelis
    Papadavid, Evangelia
    Papakonstantis, Markos
    Roussaki-Schulze, Angeliki-Viktoria
    Sotiriou, Elena
    Anastasiadis, Georgios
    Tampouratzi, Eleftheria
    Chasapi, Vasiliki
    Sfaelos, Konstantinos
    Ioannides, Dimitrios
    DERMATOLOGIC THERAPY, 2022, 35 (12)
  • [28] Risankizumab in obese patients with moderate-to-severe plaque psoriasis: a 104-week, real-world, retrospective study
    Natalia Rompoti
    Ioannis-Alexios Koumprentziotis
    Irene Stefanaki
    Charitomeni Vavouli
    Marina Papoutsaki
    Maria Politou
    Pantelis Panagakis
    Angeliki Befon
    Fiori Kousta
    Eleni Lazou
    Vasiliki Chasapi
    Alexander Stratigos
    Electra Nicolaidou
    Archives of Dermatological Research, 316 (9)
  • [29] Efficacy of switching from ustekinumab to guselkumab in patients with moderate-to-severe plaque psoriasis: Results from the NAVIGATE study
    Langley, Richard G.
    Tsai, Tsen-Fang
    Flavin, Susan
    Song, Michael
    Randazzo, Bruce
    Wasfi, Yasmine
    Li, Shu
    Puig, Luis
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2017, 76 (06) : AB120 - AB120
  • [30] The Effectiveness of Risankizumab Following Guselkumab Failure in Moderate-to-Severe Psoriasis Patients: A Retrospective Study
    Hamm, Camille
    Ramsoondar, Nusha
    McGillis, Michaela
    Waugh, Miranda
    Gooderham, Melinda
    Giroux, Lyne L.
    JOURNAL OF CUTANEOUS MEDICINE AND SURGERY, 2023, 27 (05) : 476 - 480
12345